Discriminative stimulus properties of Δ9-tetrahydrocannabinol (THC) in C57Bl/6J mice

European Journal of Pharmacology

Volumn 615, Issue 1-3, 2009, Pages 102-107

  Vann, Robert E ^a   Warner, Jonathan A ^a   Bushell, Kristen ^b   Huffman, John W ^b   Martin, Billy R ^a   Wiley, Jenny L ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b CLEMSON UNIVERSITY   (United States)

Author keywords

(Mouse); Anandamide; Cannabinoid; Drug discrimination; THC

Indexed keywords

BENZYLSULFONYL FLUORIDE; CANNABINOID 1 RECEPTOR; CANNABINOID DERIVATIVE; DRONABINOL; RIMONABANT;

ANIMAL EXPERIMENT; ARTICLE; BINDING AFFINITY; CHEMICAL ANALYSIS; CHEMICAL STRUCTURE; CONTROLLED STUDY; DISCRIMINATIVE STIMULUS; MALE; MOUSE; NONHUMAN; PERCEPTIVE DISCRIMINATION; PRIORITY JOURNAL; RECEPTOR BINDING; STRUCTURE ANALYSIS;

AMIDOHYDROLASES; ANIMALS; ARACHIDONIC ACIDS; DISCRIMINATION (PSYCHOLOGY); DISCRIMINATION LEARNING; DOSE-RESPONSE RELATIONSHIP, DRUG; HALLUCINOGENS; MALE; MICE; MICE, INBRED C57BL; NICOTINE; PHENYLMETHYLSULFONYL FLUORIDE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; TETRAHYDROCANNABINOL;

EID: 67449168117     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2009.05.010     Document Type: Article

References (50)

1. Adams I.B., Ryan W., Singer M., Thomas B.F., Compton D.R., Razdan R.K., and Martin B.R. Evaluation of cannabinoid receptor binding and in vivo activities for anandamide analogs. J. Pharmacol. Exp. Ther. 273 (1995) 1172-1181
2. Balster R.L., and Moser V.C. Pentobarbital discrimination in the mouse. Alcohol Drug Res. 7 (1987) 233-242
3. Balster R.L., and Prescott W.R. Δ9-Tetrahydrocannabinol discrimination in rats as a model for cannabis intoxication. Neurosci. Biobehav. Rev. 16 (1992) 55-62
4. Barrett R.L., Wiley J.L., Balster R.L., and Martin B.R. Pharmacological specificity of delta 9-tetrahydrocannabinol discrimination in rats. Psychopharmacology 118 (1995) 419-424
5. Benneyworth M.A., Smith R.L., Barrett R.J., and Sanders-Bush E. Complex discriminative stimulus properties of (+)lysergic acid diethylamide (LSD) in C57Bl/6J mice. Psychopharmacology 179 (2005) 854-862
6. Bowen S.E., and Balster R.L. Desflurane, enflurane, isoflurane and ether produce ethanol-like discriminative stimulus effects in mice. Pharmacol. Biochem. Behav. 57 (1997) 191-198
7. Burkey R.T., and Nation J.R. (R)-methanandamide, but not anandamide, substitutes for delta 9-THC in a drug-discrimination procedure. Exp. Clin. Psychopharmacol. 5 (1997) 195-202
8. Chait L.D., Evans S.M., Grant K.A., Kamien J.B., Johanson C.E., and Schuster C.R. Discriminative stimulus and subjective effects of smoked marijuana in humans. Psychopharmacology 94 (1988) 206-212
9. Compton D.R., Rice K.C., De Costa B.R., Razdan R.K., Melvin L.S., Johnson M.R., and Martin B.R. Cannabinoid structure-activity relationships: correlation of receptor binding and in vivo activities. J. Pharmacol. Exp. Ther. 265 (1993) 218-226
10. Cravatt B.F., Demarest K., Patricelli M.P., Bracey M.H., Giang D.K., Martin B.R., and Lichtman A.H. Supersensitivity to anandamide and enhanced endogenous cannabinoid signaling in mice lacking fatty acid amide hydrolase. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9371-9376
11. Desarnaud F., Cadas H., and Piomelli D. Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J. Biol. Chem. 270 (1995) 6030-6035
12. Elliot E.E., Sibley D.R., and Katz J.L. Locomotor and discriminative-stimulus effects of cocaine in dopamine D5 receptor knockout mice. Psychopharmacology 169 (2003) 161-168
13. Henriksson B.G., Johansson J.O., and Järbe T.U. Delta 9-tetrahydrocannabinol produced discrimination in pigeons. Pharmacol. Biochem. Behav. 3 (1975) 771-774
14. Huffman J.W., Szklennik P.V., Almond A., Bushell K., Selley D.E., He H., Cassidy M.P., Wiley J.L., and Martin B.R. 1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indoles. Bioorg. Med. Chem. Lett. 15 (2005) 4110-4113
15. Järbe T.U., and McMillan D.E. Delta 9-THC as a discriminative stimulus in rats and pigeons: generalization to THC metabolites and SP-111. Psychopharmacology 71 (1980) 281-289
16. Järbe T.U., Johansson J.O., and Henriksson B.G. Delta9-tetrahydrocannabinol and pentobarbital as discriminative cues in the Mongolian Gerbil (Meriones unguiculatus). Pharmacol. Biochem. Behav. 3 (1975) 403-410
17. Järbe T.U., Lamb R.J., Makriyannis A., Lin S., and Goutopoulos A. Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats. Psychopharmacology 140 (1998) 519-522
18. Järbe T.U., Lamb R.J., Lin S., and Makriyannis A. Delta9-THC training dose as a determinant for (R)-methanandamide generalization in rats: a systematic replication. Behav. Pharmacol. 11 (2000) 81-86
19. Järbe T.U., Lamb R.J., Lin S., and Makriyannis A. (R)-methanandamide and Delta 9-THC as discriminative stimuli in rats: tests with the cannabinoid antagonist SR-141716 and the endogenous ligand anandamide. Psychopharmacology 156 (2001) 369-380
20. Järbe T.U., Liu Q., and Makriyannis A. Antagonism of discriminative stimulus effects of delta(9)-THC and (R)-methanandamide in rats. Psychopharmacology 184 (2006) 36-45
21. Lile J.A., Kelly T.H., Pinsky D.J., and Hays L.R. Substitution profile of Delta(9)-tetrahydrocannabinol, triazolam, hydromorphone, and methylphenidate in humans discriminating Delta(9)-tetrahydrocannabinol. Psychopharmacology (2008) (epub 10.1007/s00213-00008-01393-00213)
22. Martin B.R., Compton D.R., Thomas B.F., Prescott W.R., Little P.J., Razdan R.K., Johnson M.R., Melvin L.S., Mechoulam R., and Ward S.J. Behavioral, biochemical, and molecular modeling evaluations of cannabinoid analogs. Pharmacol. Biochem. Behav. 40 (1991) 471-478
23. McMahon L.R. Apparent affinity estimates of rimonabant in combination with anandamide and chemical analogs of anandamide in rhesus monkeys discriminating Delta(9)-tetrahydrocannabinol. Psychopharmacology (2008) 10.1007/s00213-00008-01230-00218
24. McMahon L.R., Ginsburg B.C., and Lamb R.J. Cannabinoid agonists differentially substitute for the discriminative stimulus effects of Delta(9)-tetrahydrocannabinol in C57BL/6J mice. Psychopharmacology 198 (2008) 487-495
25. National Research Council. Guide for the Care and Use of Laboratory Animals (1996), National Academy Press, Washington, D.C.
26. Philibin S.D., Prus A.J., Pehrson A.L., and Porter J.H. Serotonin receptor mechanisms mediate the discriminative stimulus properties of the atypical antipsychotic clozapine in C57BL/6 mice. Psychopharmacology 180 (2005) 49-56
27. Picciotto M.R., and Wickman K. Using knockout and transgenic mice to study neurophysiology and behavior. Physiol. Rev. 78 (1998) 1131-1163
28. Robinson S.E., Vann R.E., Britton A.F., O'Connell M.M., James J.R., and Rosecrans J.A. Cellular nicotinic receptor desensitization correlates with nicotine-induced acute behavioral tolerance in rats. Psychopharmacology 192 (2007) 71-78
29. Shoaib M., Gommans J., Morley A., Stolerman I.P., Grailhe R., and Changeux J.P. The role of nicotinic receptor beta-2 subunits in nicotine discrimination and conditioned taste aversion. Neuropharmacology 42 (2002) 530-539
30. Smith R.L., Barrett R.J., and Sanders-Bush E. Discriminative stimulus properties of 1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane [(+/-)DOI] in C57BL/6J mice. Psychopharmacology 166 (2003) 61-68
31. Smith J.W., Mogg A., Tafi E., Peacey E., Pullar I.A., Szekeres P., and Tricklebank M. Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat. Psychopharmacology 190 (2007) 157-170
32. Solinas M., Tanda G., Justinova Z., Wertheim C.E., Yasar S., Piomelli D., Vadivel S.K., Makriyannis A., and Goldberg S.R. The endogenous cannabinoid anandamide produces delta-9-tetrahydrocannabinol-like discriminative and neurochemical effects that are enhanced by inhibition of fatty acid amide hydrolase but not by inhibition of anandamide transport. J. Pharmacol. Exp. Ther. 321 (2007) 370-380
33. Stolerman I.P., Naylor C., Elmer G.I., and Goldberg S.R. Discrimination and self-administration of nicotine by inbred strains of mice. Psychopharmacology 141 (1999) 297-306
34. Stolerman I.P., Chamberlain S., Bizarro L., Fernandes C., and Schalkwyk L. The role of nicotinic receptor alpha 7 subunits in nicotine discrimination. Neuropharmacology 46 (2004) 363-371
35. Tallarida, R., Murray, R., 1987. Springer Verlag, New York.
36. Vann R.E., Cook C.D., Martin B.R., and Wiley J.L. Cannabimimetic properties of ajulemic acid. J. Pharmacol. Exp. Ther. 320 (2007) 678-686
37. Varvel S.A., James J.R., Bowen S., Rosecrans J.A., and Karan L.D. Discriminative stimulus (DS) properties of nicotine in the C57BL/6 mouse. Pharmacol. Biochem. Behav. 63 (1999) 27-32
38. Wiley J.L. Cannabis: discrimination of "internal bliss"?. Pharmacol. Biochem. Behav. 64 (1999) 257-260
39. Wiley J.L., Barrett R.L., Lowe J., Balster R.L., and Martin B.R. Discriminative stimulus effects of CP 55,940 and structurally dissimilar cannabinoids in rats. Neuropharmacology 34 (1995) 669-676
40. Wiley J.L., Huffman J.W., Balster R.L., and Martin B.R. Pharmacological specificity of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rhesus monkeys. Drug Alcohol Depend. 40 (1995) 81-86
41. Wiley J.L., Lowe J.A., Balster R.L., and Martin B.R. Antagonism of the discriminative stimulus effects of delta 9-tetrahydrocannabinol in rats and rhesus monkeys. J. Pharmacol. Exp. Ther. 275 (1995) 1-6
42. Wiley J.L., Golden K.M., Ryan W.J., Balster R.L., Razdan R.K., and Martin B.R. Evaluation of cannabimimetic discriminative stimulus effects of anandamide and methylated fluoroanandamide in rhesus monkeys. Pharmacol. Biochem. Behav. 58 (1997) 1139-1143
43. Wiley J.L., Compton D.R., Dai D., Lainton J.A., Phillips M., Huffman J.W., and Martin B.R. Structure-activity relationships of indole- and pyrrole-derived cannabinoids. J. Pharmacol. Exp. Ther. 285 (1998) 995-1004
44. Wiley J.L., Ryan W.J., Razdan R.K., and Martin B.R. Evaluation of cannabimimetic effects of structural analogs of anandamide in rats. Eur. J. Pharmacol. 355 (1998) 113-118
45. Wiley J.L., Dewey M.A., Jefferson R.G., Winckler R.L., Bridgen D.T., Willoughby K.A., and Martin B.R. Influence of phenylmethylsulfonyl fluoride on anandamide brain levels and pharmacological effects. Life Sci. 67 (2000) 1573-1583
46. Wiley J.L., LaVecchia K.L., Karp N.E., Kulasegram S., Mahadevan A., Razdan R.K., and Martin B.R. A comparison of the discriminative stimulus effects of delta(9)-tetrahydrocannabinol and O-1812, a potent and metabolically stable anandamide analog, in rats. Exp. Clin. Psychopharmacol. 12 (2004) 173-179
47. Wiley J.L., Razdan R.K., and Martin B.R. Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice. Life Sci. 80 (2006) 24-35
48. Wright Jr. M.J., Vann R.E., Gamage T.F., Damaj M.I., and Wiley J.L. Comparative effects of dextromethorphan and dextrorphan on nicotine discrimination in rats. Pharmacol. Biochem. Behav. 85 (2006) 507-513
49. Zaniewska M., McCreary A.C., Przegalinski E., and Filip M. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats. Eur. J. Pharmacol. 540 (2006) 96-106
50. Zimmer A., Zimmer A.M., Hohmann A.G., Herkenham M., and Bonner T.I. Increased mortality, hypoactivity, and hypoalgesia in cannabinoid CB1 receptor knockout mice. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 5780-5785